LBRX logo

LB Pharmaceuticals Inc Common Stock

LBRX
Healthcare|Biotechnology|US
$42.01
+3.92 (+10.29%)
DCF Value
$9.67
Tangible Book / Share
$12.63
Cash / Share
$12.21

Ownership Breakdown

82.3%
Float
32.3M
Shares Outstanding
26.5M
Float Shares

Major Holders (28)

Combined: 181.9%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
David KroinIndividual11.70%3,352,804Feb 10, 202613D/G
Deep Track Capital, LPInvestment adviser11.70%3,352,804Feb 10, 202613D/G
Deep Track Biotechnology Master Fund, Ltd.Other9.40%2,686,138Feb 10, 202613D/G
RA Capital Management, L.P.IA, PN8.70%2,208,604Feb 17, 202613D/G
Peter KolchinskyHC, IN8.70%2,208,604Feb 17, 202613D/G
Rajeev ShahHC, IN8.70%2,208,604Feb 17, 202613D/G
RA Capital Healthcare Fund, L.P.Partnership8.70%2,208,604Feb 17, 202613D/G
Michael KramarzHC, IN6.80%1,972,369May 15, 202613D/G
Robert Egen AtkinsonHC, IN6.80%1,972,369May 15, 202613D/G
Commodore Capital Master LPPartnership6.80%1,972,369May 15, 202613D/G
Commodore Capital LPIA, PN6.80%1,972,369May 15, 202613D/G
BlackRock, Inc.Holding company6.30%1,796,543Jul 29, 202613D/G
Ran NussbaumIndividual6.30%1,411,681Sep 25, 202513D/G
Pontifax VI G.P. L.P.Partnership6.30%1,411,681Sep 25, 202513D/G
Pontifax Management 4 G.P. (2015) Ltd.Corporation6.30%1,411,681Sep 25, 202513D/G
Tomer KarivIndividual6.30%1,411,681Sep 25, 202513D/G
Jpmorgan Chase & CoHolding company5.20%1,497,293Jul 16, 202613D/G
TCG Crossover GP II, LLCOther5.00%1,447,310Aug 14, 202613D/G
Chen YuIndividual5.00%1,447,310Aug 14, 202613D/G
TCG Crossover Fund II, L.P.Partnership5.00%1,447,310Aug 14, 202613D/G
Caligan Partners LPIA, PN5.00%1,438,070May 15, 202613D/G
Johnson David EdwardHC, IN5.00%1,438,070May 15, 202613D/G
Trails Edge Biotechnology Master Fund, LPPartnership5.00%1,268,265Dec 31, 202513D/G
Trails Edge Capital Partners, LPIA, PN5.00%1,268,265Dec 31, 202513D/G
Ortav YehudaiIndividual5.00%1,268,265Dec 31, 202513D/G
Jpmorgan Chase & Co.Holding company4.30%1,401,790Oct 13, 202613D/G
BlackRock Portfolio Management LLCHolding company3.80%961,158Jan 21, 202613D/G
Deep Track Special Opportunities Fund, LPPartnership2.30%666,666Feb 10, 202613D/G

Insider Trades (5)

InsiderPositionDateTypeSharesPriceValueFiling
Miller Joseph MChief Financial OfficerOct 9, 2026AWARD200,000$37.22$7.4MForm 4
Kozauer Susan GaniChief Medical OfficerOct 9, 2026AWARD200,000$37.22$7.4MForm 4
Kozauer Susan GaniSep 14, 2026OTHER0——Form 4
Miller Joseph MSep 2, 2026OTHER0——Form 4
Deep Track Biotechnology Master Fund, Ltd.10 percent ownerJul 30, 2026BUY286,205$0.00$28.62Form 4